Dr. Valerie Oriol Mathieu (Janssen Vaccines & Prevention): Ebola & Filoviruses Vaccine Devel
At ISNTD d³ 2017, Dr. Valerie Oriol Mathieu, Global Medical Affairs Lead at Janssen Vaccines & Prevention, speaks about current challeng
Infectious Thoughts Interview: Dr. Benny Baeten (Johnson & Johnson)
Dr. Benny Baeten, Compound Development Team Leader for Anthelmintics at the Janssen Pharmaceutical Companies of Johnson & Johnson speaks
Panel discussion: New frontiers in diagnostic development for NTDs May 2017
Panelists include:
• Pr. Rosanna Peeling (London School of Hygiene & Tropical Medicine)
• Dr. Laurence Flevaud (Médecins Sans Frontières
Panel discussion: Current gaps & research priorities for NTD drug discovery May 2017
Panel discussion at ISNTD d³ 2017, chaired by Mr. Duc H. Le, Editor in Chief at EBio Medicine. Panelists are: • Dr. Benny Baeten (J&J...
Dr. Benny Baeten (J&J Global Health): Solutions for Soil-Transmitted Helminths & Onchocercia
At ISNTD d³ 2017, Dr. Benny Baeten, Compound Development Team Leader Anthelmintics at Janssen Pharmaceutica (a J&J Global Health company
Panel discussion: Current gaps & research priorities for NTD drug discovery May 2017
Panel discussion at ISNTD d³ 2017, chaired by Mr. Duc H. Le, Editor in Chief at EBio Medicine.
Panelists are:
• Dr. Benny Baeten (J&J
Dr. Ole Lagatie, (Senior Principal Research Scientist at Janssen Diagnostics)
The ISNTD catches up with Dr. Ole Lagatie, Senior Principal Research Scientist at Janssen Diagnostics, to discuss current research and tools
